Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer - Reply

Joseph A. Sparano

doi:10.1001/jamaoncol.2019.6712

Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer - Reply

Joseph A. Sparano

Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	586
Number of pages	1
Journal	JAMA Oncology
Volume	6
Issue number	4
DOIs	https://doi.org/10.1001/jamaoncol.2019.6712
State	Published - Apr 2020

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2019.6712

Cite this

@article{720341f920194af3bdc365291575430c,

title = "Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer - Reply",

author = "Sparano, {Joseph A.}",

year = "2020",

month = apr,

doi = "10.1001/jamaoncol.2019.6712",

language = "English (US)",

volume = "6",

pages = "586",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "4",

}

TY - JOUR

T1 - Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer - Reply

AU - Sparano, Joseph A.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85083908685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083908685&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2019.6712

DO - 10.1001/jamaoncol.2019.6712

M3 - Letter

C2 - 32053157

AN - SCOPUS:85083908685

SN - 2374-2437

VL - 6

SP - 586

JO - JAMA Oncology

JF - JAMA Oncology

IS - 4

ER -

Use of the 21-Gene Recurrence Score to Predict Clinical Outcomes in Early Breast Cancer - Reply

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this